Portugal

Elderly. Study proposes vaccine against syncytial virus

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 07/10/2026, 11:46:25 UTC.

Briefings

A study reports that among patients hospitalized for acute respiratory infections, the Respiratory Syncytial Virus (RSV) was identified in 345 cases. The evidence indicates that nearly one in five adults with RSV did not survive the hospitalization period.

Key points

• The Respiratory Syncytial Virus (RSV) was identified in 345 patients hospitalized for acute respiratory infections.
• Nearly one in five adults hospitalized with RSV did not survive the hospitalization period.

Context

This finding highlights a significant mortality risk for hospitalized adults with RSV, as nearly 20% of cases resulted in death during hospitalization.

Limitations

The evidence is limited to a single study with a snapshot of 345 cases. The specific date of the study is not provided, and the survival rate applies only to hospitalized adults, not all RSV cases.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 27/10/2026, 19:04:43 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiggdsrjlk6tshwn3n52akafk5fmpahcxpmhoyumq7l7zdkg5fqhiy